Somatic mutations identified at diagnosis by exome sequencing can predict response to imatinib in chronic phase CML patients
Source: American Journal of Hematology - Category: Hematology Authors: Luca Mologni, Rocco Piazza, Praveen Khandelwal, Alessandra Pirola, Carlo Gambacorti ‐Passerini Tags: Correspondence Source Type: research
More News: Gleevec | Hematology